These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Quinols as novel therapeutic agents. 2.(1) 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agents. Berry JM; Bradshaw TD; Fichtner I; Ren R; Schwalbe CH; Wells G; Chew EH; Stevens MF; Westwell AD J Med Chem; 2005 Jan; 48(2):639-44. PubMed ID: 15658878 [TBL] [Abstract][Full Text] [Related]
3. Quinols as novel therapeutic agents. 7.1 Synthesis of antitumor 4-[1-(arylsulfonyl-1H-indol-2-yl)]-4-hydroxycyclohexa-2,5-dien-1-ones by Sonogashira reactions. McCarroll AJ; Bradshaw TD; Westwell AD; Matthews CS; Stevens MF J Med Chem; 2007 Apr; 50(7):1707-10. PubMed ID: 17343370 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological testing of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxin analogues as antitumor agents. Reddy PB; Paul DV; Agrawal SK; Saxena AK; Kumar HM; Qazi GN Arch Pharm (Weinheim); 2008 Feb; 341(2):126-31. PubMed ID: 18214838 [TBL] [Abstract][Full Text] [Related]
5. A novel, broad-spectrum antitumor compound containing the 1-hydroxycyclohexa-2,5-dien-4-one group: the disclosure of a new antitumor pharmacophore in protoapigenone 1. Yuan Q; Liu Z; Xiong C; Wu L; Wang J; Ruan J Bioorg Med Chem Lett; 2011 Jun; 21(11):3427-30. PubMed ID: 21515048 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor activity studies of some new fused 1,2,4-triazole derivatives carrying 2,4-dichloro-5-fluorophenyl moiety. Bhat KS; Poojary B; Prasad DJ; Naik P; Holla BS Eur J Med Chem; 2009 Dec; 44(12):5066-70. PubMed ID: 19822384 [TBL] [Abstract][Full Text] [Related]
7. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin. Odlo K; Hentzen J; dit Chabert JF; Ducki S; Gani OA; Sylte I; Skrede M; Flørenes VA; Hansen TV Bioorg Med Chem; 2008 May; 16(9):4829-38. PubMed ID: 18396050 [TBL] [Abstract][Full Text] [Related]
8. New 5-substituted thiazolo[3,2-b][1,2,4]triazol-6-ones: synthesis and anticancer evaluation. Lesyk R; Vladzimirska O; Holota S; Zaprutko L; Gzella A Eur J Med Chem; 2007 May; 42(5):641-8. PubMed ID: 17303290 [TBL] [Abstract][Full Text] [Related]
10. An efficient one-pot synthesis of heterocycle-fused 1,2,3-triazole derivatives as anti-cancer agents. Yan SJ; Liu YJ; Chen YL; Liu L; Lin J Bioorg Med Chem Lett; 2010 Sep; 20(17):5225-8. PubMed ID: 20655212 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and antiproliferative evaluation of 3,5-disubstituted 1,2,4-triazoles containing flurophenyl and trifluoromethanephenyl moieties. Wang LY; Tseng WC; Wu TS; Kaneko K; Takayama H; Kimura M; Yang WC; Wu JB; Juang SH; Wong FF Bioorg Med Chem Lett; 2011 Sep; 21(18):5358-62. PubMed ID: 21802949 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of substituted-phenyl-1,2,4-triazol-3-thione analogues with modified D-glucopyranosyl residues and their antiproliferative activities. Li Z; Gu Z; Yin K; Zhang R; Deng Q; Xiang J Eur J Med Chem; 2009 Nov; 44(11):4716-20. PubMed ID: 19560842 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, structure elucidation and antitumour activity of N-substituted amides of 3-(3-ethylthio-1,2,4-triazol-5-yl)propenoic acid. Pachuta-Stec A; Rzymowska J; Mazur L; Mendyk E; Pitucha M; Rzaczyńska Z Eur J Med Chem; 2009 Sep; 44(9):3788-93. PubMed ID: 19482385 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand. Marzano C; Pellei M; Colavito D; Alidori S; Lobbia GG; Gandin V; Tisato F; Santini C J Med Chem; 2006 Dec; 49(25):7317-24. PubMed ID: 17149861 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and cytotoxicity evaluation of novel 1,4-disubstituted 1,2,3-triazoles via CuI catalysed 1,3-dipolar cycloaddition. Vantikommu J; Palle S; Reddy PS; Ramanatham V; Khagga M; Pallapothula VR Eur J Med Chem; 2010 Nov; 45(11):5044-50. PubMed ID: 20833451 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxins as potential anticancer agents. Reddy PB; Agrawal SK; Singh S; Bhat BA; Saxena AK; Kumar HM; Qazi GN Chem Biodivers; 2008 Sep; 5(9):1792-802. PubMed ID: 18816530 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of 4β-triazole-podophyllotoxin derivatives by azide-alkyne cycloaddition and biological evaluation as potential antitumor agents. Chen H; Zuo S; Wang X; Tang X; Zhao M; Lu Y; Chen L; Liu J; Liu Y; Liu D; Zhang S; Li T Eur J Med Chem; 2011 Sep; 46(9):4709-14. PubMed ID: 21821321 [TBL] [Abstract][Full Text] [Related]
18. Thioamido coordination in a thioxo-1,2,4-triazole copper(II) complex enhances nonapoptotic programmed cell death associated with copper accumulation and oxidative stress in human cancer cells. Tardito S; Bussolati O; Maffini M; Tegoni M; Giannetto M; Dall'asta V; Franchi-Gazzola R; Lanfranchi M; Pellinghelli MA; Mucchino C; Mori G; Marchio L J Med Chem; 2007 Apr; 50(8):1916-24. PubMed ID: 17373781 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and antimicrobial activities of some new 1-(5-phenylamino-[1,3,4]thiadiazol-2-yl)methyl-5-oxo-[1,2,4]triazole and 1-(4-phenyl-5-thioxo-[1,2,4]triazol-3-yl)methyl-5-oxo- [1,2,4]triazole derivatives. Demirbas N; Karaoglu SA; Demirbas A; Sancak K Eur J Med Chem; 2004 Sep; 39(9):793-804. PubMed ID: 15337292 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel indolyl-1,2,4-triazoles as potent and selective anticancer agents. Kumar D; Narayanam MK; Chang KH; Shah K Chem Biol Drug Des; 2011 Mar; 77(3):182-8. PubMed ID: 21251232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]